Preparation and Evaluation of Sustained Release Infliximab Microspheres

References

1. 1.↵
   1. Siddiqui M. A. A.,
   2. Scott L. J.

   Spotlight on infliximab in Crohn disease and rheumatoid arthritis. Biodrugs 2006, 20 (1), 67–70.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Deng X.,
   2. Szabo S.,
   3. Chen L.,
   4. Paunovic B.,
   5. Khomenko T.,
   6. Tolstanova G.,
   7. Tarnawski A. S.,
   8. Jones M. K.,
   9. Sandor Z.

   New cell therapy using bone marrow–derived stem cells/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitis. Curr. Pharm. Des. 2011, 17 (16), 1643–1651.

   OpenUrlPubMed
3. 3.↵
   1. Guziewicz N.,
   2. Best A.,
   3. Perez-Ramirez B.,
   4. Kaplan D. L.

   Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodies. Biomaterials 2011, 32 (10), 2642–2650.

   OpenUrlPubMed
4. 4.↵
   1. Yang M. X.,
   2. Shenoy B.,
   3. Disttler M.,
   4. Patel R.,
   5. McGrath M.,
   6. Pechenov S.,
   7. Margolin A. L.

   Crystalline monoclonal antibodies for subcutaneous delivery. Proc. Natl Acad. Sci. USA 2003, 100 (12), 6934–6939.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Schweizer D.,
   2. Schonhammer K.,
   3. Jahn M.,
   4. Gopferich A.

   Protein–polyanion interactions for the controlled release of monoclonal antibodies. Biomacromolecules 2013, 14 (1), 75–83.

   OpenUrlPubMed
6. 6.↵
   1. Joung Y. K.,
   2. Son S.,
   3. Jang J. Y.,
   4. Kwon M. H.,
   5. Park K. D.

   Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody. Pharm. Res. 2012, 29 (4), 932–942.

   OpenUrlPubMed
7. 7.↵
   1. Sinha V. R.,
   2. Trehan A.

   Biodegradable microspheres for protein delivery. J. Controlled Release 2003, 90 (3), 261–280.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Vivek K.,
   2. Reddy L. H.,
   3. Murthy R. S.

   Comparative study of some biodegradable polymers on the entrapment efficiency and release behavior of etoposide from microspheres. Pharm. Dev. Technol. 2007, 12 (1), 79–88.

   OpenUrlPubMed
9. 9.↵
   1. Danhier F.,
   2. Ansorena E.,
   3. Silva J. M.,
   4. Coco R.,
   5. Le Breton, A.,
   6. Préat V.

   PLGA-based nanoparticles: an overview of biomedical applications. J. Controlled Release 2012, 161 (2), 505–522.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Park P. I.,
    2. Makoid M.,
    3. Jonnalagadda S.

    The design of flexible ciprofloxacin-loaded PLGA implants using a reversed phase separation/coacervation method. Eur. J. Pharm. Biopharm. 2011, 77 (2), 233–239.

    OpenUrlPubMed
11. 11.↵
    1. Jonnalagadda S.,
    2. Robinson D. H.

    Effect of the inclusion of PEG on the solid-state properties and drug release from polylactic acid films and microcapsules. J. Appl. Polymer Sci. 2004, 93 (5), 2025–2030.

    OpenUrl
12. 12.↵
    1. Middleton J. C.,
    2. Tipton A. J.

    Synthetic biodegradable polymers as medical devices. Med. Plas. Biomater. 1998, March/April, 31–38.

    OpenUrl
13. 13.↵
    1. Jiskoot W.,
    2. Randolph T. W.,
    3. Volkin D. B.,
    4. Middaugh C. R.,
    5. Schöneich C.,
    6. Winter G.,
    7. Friess W.,
    8. Crommelin D. J.,
    9. Carpenter J. F.

    Protein instability and immunogenicity: Roadblocks to clinical application of injectable protein delivery systems for sustained release. J. Pharm. Sci. 2011, 101 (3), 946–954.

    OpenUrlPubMed
14. 14.↵
    1. Cleland J. L.,
    2. Duenas E.,
    3. Daugherty A.,
    4. Marian M.,
    5. Yang J.,
    6. Wilson M.,
    7. Celniker A. C.,
    8. Shahzamani A.,
    9. Quarmby V.,
    10. Chu H.,
    11. Mukku V.,
    12. Mac A.,
    13. Roussakis M.,
    14. Gillette N.,
    15. Boyd B.,
    16. Yeung D.,
    17. Brooks D.,
    18. Maa Y.-F.,
    19. Hsu C.,
    20. Jones A. J. S.

    Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect. J. Controlled Release 1997, 49 (2), 193–205.

    OpenUrlCrossRefWeb of Science
15. 15.↵
    1. Graves R. L.,
    2. Makoid M. C.,
    3. Jonnalagadda S.

    The effect of coencapsulation of bovine insulin with cyclodextrins in ethylcellulose microcapsules. J. Microencapsul. 2005, 22 (6), 661–670.

    OpenUrlPubMed
16. 16.↵
    1. Cohen-Sela E.,
    2. Chorny M.,
    3. Koroukhov N.,
    4. Danenberg H. D.,
    5. Golomb G.

    A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J. Controlled Release 2009, 133 (2), 90–95.

    OpenUrlPubMed
17. 17.↵
    1. Kim H. K.,
    2. Park T. G.

    Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release. J. Controlled Release 2004, 98 (11), 115–125.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Tewes F.,
    2. Munnier E.,
    3. Antoon B.,
    4. Ngaboni Okassa L.,
    5. Cohen-Jonathan S.,
    6. Marchais H.,
    7. Douziech-Eyrolles L.,
    8. Soucé M.,
    9. Dubois P.,
    10. Chourpa I.

    Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur. J. Pharm. Biopharm. 2007, 66 (3), 488–492.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Govender T.,
    2. Stolnik S.,
    3. Garnett M. C.,
    4. Illum L.,
    5. Davis S. S.

    PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Controlled Release 1999, 57 (2), 171–185.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Stivaktakis N.,
    2. Nikou K.,
    3. Panagi Z.,
    4. Beletsi A.,
    5. Leondiadis L.,
    6. Avgoustakis K.

    PLA and PLGA microspheres of beta-galactosidase: effect of formulation factors on protein antigenicity and immunogenicity. J. Biomed. Mater. Res., A 2004, 70 (1), 139–148.

    OpenUrlPubMed
21. 21.↵
    1. Cadee J. A.,
    2. Brouwer L. A.,
    3. den Otter W.,
    4. Hennink W. E.,
    5. van Luyn M. J.

    A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats. J. Biomed. Mater. Res. 2001, 56 (4), 600–609.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Little S. R.,
    2. Lynn D. M.,
    3. Ge Q.,
    4. Anderson D. G.,
    5. Puram S. V.,
    6. Chen J.,
    7. Eisen H. N.,
    8. Langer R.

    Poly-β amino ester-containing microparticles enhance the activity of non viral genetic vaccines. Proc. Natl Acad. Sci. USA 2004, 101 (26), 9534–9539.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Nayak B.,
    2. Panda A. K.,
    3. Ray P.,
    4. Ray A. R.

    Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination. J. Microencapsul. 2009, 26 (2), 154–165.

    OpenUrlPubMed
24. 24.↵
    1. Lee E. S.,
    2. Kwon M. J.,
    3. Lee H.,
    4. Kim J. J.

    Stabilization of protein encapsulated in poly(lactide-co-glycolide) microspheres by novel viscous S/W/O/W method. Int. J. Pharm. 2007, 331 (1), 27–37.

    OpenUrlPubMed
25. 25.↵
    1. Kiese S.,
    2. Pappenberger A.,
    3. Friess W.,
    4. Mahler H.

    Shaken, not stirred: mechanical stress testing of an lgG1 antibody. J. Pharm. Sci. 2008, 97 (10), 4347–4366.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Ritger P. L.,
    2. Peppas N. A.

    A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Controlled Release 1987, 5 (1), 23–36.

    OpenUrlCrossRef
27. 27.↵
    1. Ritger P. L.,
    2. Peppas N. A.

    A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Controlled Release 1987, 5 (1), 37–42.

    OpenUrlCrossRef
28. 28.↵
    1. Higuchi T.

    Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 1961, 50 (October), 874–875.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Higuchi T.

    Mechanism of sustained action medication:theorotical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52 (December), 1145–1149.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Huang Y. Y.,
    2. Chung T. W.,
    3. Tzeng T. W.

    A method using biodegradable polylactides/polyethylene glycol for drug release with reduced initial burst. Int. J. Pharm. 1999, 182 (1), 93–100.

    OpenUrlPubMed
31. 31.↵
    1. Siepmann J.,
    2. Peppas N. A.

    Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 2001, 48 (2-3), 139–157.

    OpenUrlCrossRefPubMedWeb of Science